SC 13G

Company

Aclaris Therapeutics, Inc.

Filed

November 1, 2018

Accession Number

0001144204-18-056793

A Schedule 13G is filed when a passive investor acquires more than 5% of a company's shares without intent to influence control. Learn more about SC 13G filings →